• Twitter
Akassoglou Lab
  • Home
  • Research
  • Members
  • Publications
  • Protocols
  • Videos
  • Resources
  • Open-Access Data
  • News
  • Events
  • Contact
  • Menu Menu

Blocking p75 NTR in diabetes

April 1, 2012/0 Comments/in News, 2012 /by awp-admin

April 1, 2012

Read Science-Business eXchange article →

scibx

Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on LinkedIn
  • Share by Mail
https://akassogloulab.org/wp-content/uploads/2012/04/SciBx.jpg 145 163 awp-admin /wp-content/uploads/2017/01/katerina-akassoglou-lab-all-caps-gladstone-ucsf-501x133-new.png awp-admin2012-04-01 17:08:582017-01-18 18:25:20Blocking p75 NTR in diabetes

Latest News

  • Andrew Mendiola shared his research and his Bike MS experience at the National Multiple Sclerosis Leadership ConferenceNovember 15, 2019 - 7:12 pm
  • Mark Petersen is awarded an NIH/NINDS fellowship entitled, “Fibrinogen-Mediated Mechanisms of Preterm Infant Brain Injury.”November 10, 2019 - 7:43 pm
  • $4.5 Million to Study How Neurovascular Dysfunction Contributes to Neurodegeneration in Alzheimer’s DiseaseOctober 31, 2019 - 10:54 pm
  • New Bay Area Spin-Off Company to Develop Drugs for Multiple Sclerosis and Alzheimer’s DiseaseOctober 8, 2019 - 11:01 pm
  • Momentum, NMSS Magazine – A big part of the MS puzzleJuly 11, 2019 - 9:34 pm
More News →

Katerina Akassoglou, Ph.D.

Gladstone Institute of Neurological Disease
1650 Owens Street
San Francisco, CA 94158

415-734-2512 (Phone)
415-355-0824 (Fax)
kakassoglou@gladstone.ucsf.edu
Followon TwitterSubscribeto RSS Feed


Affiliates


GIND - Gladstone Institutes Neurological Disease

UCSF Neurology
© Copyright Akassoglou Lab. All rights reserved.
  • Twitter
  • Home
  • Research
  • Members
  • Publications
  • Protocols
  • Videos
  • Resources
  • Open-Access Data
  • News
  • Events
  • Contact
Gladstone scientists identify gene critical for cell responses to oxygen de... gladstone-square gladstone-square Gladstone scientists identify key mechanism involved in type 2 diabetes
Scroll to top